PIPages
Labs

Sonya Wang

University of Minnesota, MN·Medicine & Clinical Research

Seizures strike about 1 in 300 newborns. Many survivors, between 40% and 60%, face lasting disabilities such as cerebral palsy, developmental delay or epilepsy.

Fields

Medicine & Clinical Research

Neuroscience

Pharmacology

Topics

neonatal seizures

newborns

levetiracetam

Grants
1 known grant, through Jul 2027

What they work on

  1. Determine the maximum tolerated loading dose of levetiracetam, up to 150 mg/kg, in newborns with mild to moderate seizures through a three-phase dose escalation trial with safety review at each level.
  2. Compare seizure control from higher-dose levetiracetam against standard dose, with phenobarbital as a randomized 3:1 control in infants who keep seizing after standard treatment.
  3. Measure the pharmacokinetics of high-dose levetiracetam in newborns, meaning how their bodies absorb and clear the drug.
  4. Evaluate the accuracy of the improved Persyst neonatal seizure detection algorithm for rapid automated diagnosis of seizures.

More about the research

Seizures themselves may add to brain injury, so faster detection and safer, more effective treatment could improve long-term outcomes. A prior trial, NEOLEV2, found that phenobarbital (PHB) controlled seizures better than standard-dose levetiracetam (LEV). However, PHB caused more breathing suppression, low blood pressure and sedation, and it raises concerns about long-term effects on thinking.

Why it matters

Newborns with seizures, and their families, could benefit from a treatment approach based on seizure burden. In this approach, safer high-dose levetiracetam handles milder cases and phenobarbital, with its greater side effects, is held in reserve. More accurate automated seizure detection could allow faster treatment, which may reduce later disabilities such as cerebral palsy and epilepsy.

Known grants

From NIH and NSF research grants. Labs often have other funding we can't see.

NEOLEV3: A Phase IIb Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures of Mild to Moderate Severity IND-109622 (September 6, 2020)

NIH · Sep 2022 – Jul 2027

Closest labs

Matthew Harer

University of Wisconsin-Madison, WI·Medicine & Clinical Research

Test in a randomized trial whether an extra caffeine dose of 10 or 20 mg/kg raises kidney oxygen levels more than placebo in preterm infants under 30 weeks' gestation with low kidney oxygen measured by near-infrared spectroscopy.

Hannah Cranley Glass

University of California-San Francisco, CA·Medicine & Clinical Research

Determine whether children who develop epilepsy after acute symptomatic neonatal seizures carry more damaging single nucleotide variants and gene-rich copy number variants in known epilepsy genes than children who do not, using genetic testing in the Neonatal Seizure Registry cohort.

Sham Kakar

University of Louisville, KY·Medicine & Clinical Research

Determine the safety, tolerability and maximum tolerated dose of withaferin A, given as oral ashwagandha capsules at 2, 4 and 8 g twice daily, combined with standard liposomal doxorubicin (DOXIL) in 18 patients with platinum-resistant recurrent ovarian cancer.

The school

University of Minnesota: 88 labs on PI Pages, $1.4B a year on research, 722 research doctorates a year.

More about University of Minnesota

Reach out

A start for your email. Fill in the brackets.